http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104258414-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-686 |
| filingDate | 2014-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104258414-B |
| titleOfInvention | Autophagygene ATG10 participates in the function and application of RNA virus duplication |
| abstract | The present invention relates to new function and its applications that the gene of people's autophagygene atg10 and albumen influence RNA virus duplication, specifically (promoter sequence is related to, but are not limited to using two kinds of full length coding region (CDS) sequences of people's autophagygene atg10 and its Regulatory Sequence, first, second, third and fourth intron sequences), and two kinds of ATG10 the protein moleculars ATG10-L and ATG10-S translated by two kinds of coded sequences of atg10 gene, it is target spot or object including its sequence analogues and microRNAs etc., pass through genetic manipulation, screening, the albumen kind new medicine and Related product of the new RNA virus resisting of the research and development such as vivoexpression of protokaryon and eukaryocyteï¼›Compound research and development by screening controllable two kinds of ATG10 protein diversities expression have the new drug candidate compound of the RNA virus resisting of new action target spot. |
| priorityDate | 2014-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 226.